Skip to content
ModalisModalis
  • Home
  • About
    • Message from CEO
    • Company History
    • Leadership
  • Business
    • Pipeline
  • Science
    • Gene Therapy
    • Genome Editing:CRISPR
    • Science epigenome
    • CRISPR-GNDM®
  • News
  • Patients
  • Investors
    • Message
    • Stock
    • IR Governance
    • IR Library
    • IR Calendar
    • FAQ
  • Careers
  • Contact
  • EN
    • JP
    • EN

IR Calendar

HomeIR Information IR Calendar
  • About
    • Message from CEO
    • Company History
    • Leadership
  • Business
    • Pipeline
  • Science
    • Gene Therapy
    • Genome Editing:CRISPR
    • Science epigenome
    • CRISPR-GNDM®
  • News
  • Patients
  • Investors
    • Message
    • Stock
    • IR Governance
    • IR Library
    • IR Calendar
    • FAQ
  • Careers
  • Contact
About
Message from CEO
Company History
Leadership
Business
Pipeline
Science
Gene Therapy
Genome Editing: CRISPR
Science Epigenome
CRISPR-GNDM®
Patient
News
Investors
Message
Stock
IR Governance
IR Library
IR Calendar
FAQ
Careers
Contact
© Modalis Therapeutics Corporation
  • Home
  • About
    • Message from CEO
    • Company History
    • Leadership
  • Business
    • Pipeline
  • Science
    • Gene Therapy
    • Genome Editing:CRISPR
    • Science epigenome
    • CRISPR-GNDM®
  • News
  • Patients
  • Investors
    • Message
    • Stock
    • IR Governance
    • IR Library
    • IR Calendar
    • FAQ
  • Careers
  • Contact
  • EN
    • JP
    • EN